nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Diabetic—Captopril—systemic scleroderma	0.0446	0.0446	CcSEcCtD
Carteolol—Lacrimation—Pentoxifylline—systemic scleroderma	0.0334	0.0334	CcSEcCtD
Carteolol—Diabetic—Lisinopril—systemic scleroderma	0.0316	0.0316	CcSEcCtD
Carteolol—Cerebral ischaemia—Lisinopril—systemic scleroderma	0.0218	0.0218	CcSEcCtD
Carteolol—Lacrimation increased—Pentoxifylline—systemic scleroderma	0.0213	0.0213	CcSEcCtD
Carteolol—Cerebral ischaemia—Mycophenolate mofetil—systemic scleroderma	0.0191	0.0191	CcSEcCtD
Carteolol—Diabetic—Methotrexate—systemic scleroderma	0.0157	0.0157	CcSEcCtD
Carteolol—Keratitis—Mycophenolate mofetil—systemic scleroderma	0.0142	0.0142	CcSEcCtD
Carteolol—Diabetes mellitus—Captopril—systemic scleroderma	0.0124	0.0124	CcSEcCtD
Carteolol—Bronchospasm—Pentoxifylline—systemic scleroderma	0.0121	0.0121	CcSEcCtD
Carteolol—Respiratory failure—Mycophenolic acid—systemic scleroderma	0.0119	0.0119	CcSEcCtD
Carteolol—Cerebrovascular accident—Captopril—systemic scleroderma	0.011	0.011	CcSEcCtD
Carteolol—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.0107	0.0107	CcSEcCtD
Carteolol—Bronchospasm—Mometasone—systemic scleroderma	0.0105	0.0105	CcSEcCtD
Carteolol—Diabetes mellitus—Leflunomide—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Carteolol—Photophobia—Lisinopril—systemic scleroderma	0.00989	0.00989	CcSEcCtD
Carteolol—Diabetes mellitus—Mycophenolic acid—systemic scleroderma	0.00976	0.00976	CcSEcCtD
Carteolol—Respiratory failure—Mycophenolate mofetil—systemic scleroderma	0.0094	0.0094	CcSEcCtD
Carteolol—Cardiac failure congestive—Mycophenolic acid—systemic scleroderma	0.00936	0.00936	CcSEcCtD
Carteolol—Conjunctivitis—Mometasone—systemic scleroderma	0.00921	0.00921	CcSEcCtD
Carteolol—Bronchospasm—Captopril—systemic scleroderma	0.00918	0.00918	CcSEcCtD
Carteolol—Sinusitis—Mometasone—systemic scleroderma	0.00889	0.00889	CcSEcCtD
Carteolol—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00881	0.00881	CcSEcCtD
Carteolol—Diabetes mellitus—Lisinopril—systemic scleroderma	0.00879	0.00879	CcSEcCtD
Carteolol—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.0087	0.0087	CcSEcCtD
Carteolol—Photophobia—Mycophenolate mofetil—systemic scleroderma	0.00867	0.00867	CcSEcCtD
Carteolol—Dysgeusia—Pentoxifylline—systemic scleroderma	0.0084	0.0084	CcSEcCtD
Carteolol—Vision blurred—Pentoxifylline—systemic scleroderma	0.00809	0.00809	CcSEcCtD
Carteolol—Hypoglycaemia—Lisinopril—systemic scleroderma	0.00784	0.00784	CcSEcCtD
Carteolol—Cerebrovascular accident—Lisinopril—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Carteolol—Diabetes mellitus—Mycophenolate mofetil—systemic scleroderma	0.0077	0.0077	CcSEcCtD
Carteolol—Diplopia—Lisinopril—systemic scleroderma	0.00765	0.00765	CcSEcCtD
Carteolol—Palpitations—Pentoxifylline—systemic scleroderma	0.00758	0.00758	CcSEcCtD
Carteolol—Cardiac failure congestive—Mycophenolate mofetil—systemic scleroderma	0.00739	0.00739	CcSEcCtD
Carteolol—Visual disturbance—Mycophenolate mofetil—systemic scleroderma	0.00707	0.00707	CcSEcCtD
Carteolol—Oedema—Pentoxifylline—systemic scleroderma	0.007	0.007	CcSEcCtD
Carteolol—Shock—Pentoxifylline—systemic scleroderma	0.00689	0.00689	CcSEcCtD
Carteolol—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Carteolol—Cerebrovascular accident—Mycophenolate mofetil—systemic scleroderma	0.00684	0.00684	CcSEcCtD
Carteolol—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.0067	0.0067	CcSEcCtD
Carteolol—Conjunctivitis—Leflunomide—systemic scleroderma	0.00667	0.00667	CcSEcCtD
Carteolol—Hypotension—Pentoxifylline—systemic scleroderma	0.00654	0.00654	CcSEcCtD
Carteolol—Bronchospasm—Lisinopril—systemic scleroderma	0.0065	0.0065	CcSEcCtD
Carteolol—Sinusitis—Leflunomide—systemic scleroderma	0.00643	0.00643	CcSEcCtD
Carteolol—Dysgeusia—Captopril—systemic scleroderma	0.00637	0.00637	CcSEcCtD
Carteolol—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.00636	0.00636	CcSEcCtD
Carteolol—Insomnia—Pentoxifylline—systemic scleroderma	0.00633	0.00633	CcSEcCtD
Carteolol—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00624	0.00624	CcSEcCtD
Carteolol—Sinusitis—Mycophenolic acid—systemic scleroderma	0.00614	0.00614	CcSEcCtD
Carteolol—Vision blurred—Captopril—systemic scleroderma	0.00613	0.00613	CcSEcCtD
Carteolol—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00598	0.00598	CcSEcCtD
Carteolol—Depression—Lisinopril—systemic scleroderma	0.00588	0.00588	CcSEcCtD
Carteolol—Syncope—Captopril—systemic scleroderma	0.00583	0.00583	CcSEcCtD
Carteolol—Arrhythmia—Azathioprine—systemic scleroderma	0.00582	0.00582	CcSEcCtD
Carteolol—Palpitations—Captopril—systemic scleroderma	0.00575	0.00575	CcSEcCtD
Carteolol—Loss of consciousness—Captopril—systemic scleroderma	0.00572	0.00572	CcSEcCtD
Carteolol—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00566	0.00566	CcSEcCtD
Carteolol—Sinusitis—Lisinopril—systemic scleroderma	0.00553	0.00553	CcSEcCtD
Carteolol—Arrhythmia—Leflunomide—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Carteolol—Dyspnoea—Mometasone—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Carteolol—Bradycardia—Lisinopril—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Carteolol—Respiratory failure—Methotrexate—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Carteolol—Dysgeusia—Leflunomide—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Carteolol—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Carteolol—Diabetes mellitus—Prednisone—systemic scleroderma	0.00522	0.00522	CcSEcCtD
Carteolol—Shock—Captopril—systemic scleroderma	0.00522	0.00522	CcSEcCtD
Carteolol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Carteolol—Depression—Mycophenolate mofetil—systemic scleroderma	0.00515	0.00515	CcSEcCtD
Carteolol—Vision blurred—Leflunomide—systemic scleroderma	0.00505	0.00505	CcSEcCtD
Carteolol—Asthenia—Pentoxifylline—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Carteolol—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Carteolol—Cardiac failure congestive—Prednisone—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Carteolol—Hypotension—Captopril—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Carteolol—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Carteolol—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Carteolol—Insomnia—Captopril—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Carteolol—Palpitations—Leflunomide—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Carteolol—Dyspnoea—Captopril—systemic scleroderma	0.00473	0.00473	CcSEcCtD
Carteolol—Arrhythmia—Lisinopril—systemic scleroderma	0.00473	0.00473	CcSEcCtD
Carteolol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00472	0.00472	CcSEcCtD
Carteolol—Dizziness—Pentoxifylline—systemic scleroderma	0.00463	0.00463	CcSEcCtD
Carteolol—Syncope—Mycophenolic acid—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Carteolol—Palpitations—Mycophenolic acid—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Carteolol—Dysgeusia—Lisinopril—systemic scleroderma	0.00451	0.00451	CcSEcCtD
Carteolol—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00449	0.00449	CcSEcCtD
Carteolol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Carteolol—Headache—Pentoxifylline—systemic scleroderma	0.00439	0.00439	CcSEcCtD
Carteolol—Diabetes mellitus—Methotrexate—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Carteolol—Vision blurred—Lisinopril—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Carteolol—Asthenia—Mometasone—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Carteolol—Hypotension—Azathioprine—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Carteolol—Oedema—Mycophenolic acid—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Carteolol—Nausea—Pentoxifylline—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Carteolol—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Carteolol—Syncope—Lisinopril—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Carteolol—Shock—Mycophenolic acid—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Carteolol—Hypotension—Leflunomide—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Carteolol—Palpitations—Lisinopril—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Carteolol—Loss of consciousness—Lisinopril—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Carteolol—Visual disturbance—Methotrexate—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Carteolol—Insomnia—Leflunomide—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Carteolol—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Carteolol—Dyspnoea—Leflunomide—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Carteolol—Hypotension—Mycophenolic acid—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Carteolol—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Carteolol—Asthenia—Captopril—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Carteolol—Headache—Mometasone—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Carteolol—Insomnia—Mycophenolic acid—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Carteolol—Oedema—Lisinopril—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Carteolol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Carteolol—Shock—Lisinopril—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Carteolol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Carteolol—Nausea—Mometasone—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Carteolol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Carteolol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Carteolol—Hypotension—Lisinopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Carteolol—Dizziness—Captopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Carteolol—Depression—Prednisone—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Carteolol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Carteolol—Insomnia—Lisinopril—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Carteolol—Dyspnoea—Lisinopril—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Carteolol—Headache—Captopril—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Carteolol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Carteolol—Shock—Mycophenolate mofetil—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Carteolol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Carteolol—Bradycardia—Prednisone—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Carteolol—Nausea—Captopril—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Carteolol—Asthenia—Leflunomide—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Carteolol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Carteolol—Dizziness—Azathioprine—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Carteolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Carteolol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Carteolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Carteolol—Depression—Methotrexate—systemic scleroderma	0.00292	0.00292	CcSEcCtD
Carteolol—Headache—Azathioprine—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Carteolol—Dizziness—Leflunomide—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Carteolol—Arrhythmia—Prednisone—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Carteolol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Carteolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Carteolol—Nausea—Azathioprine—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Carteolol—Headache—Leflunomide—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Carteolol—Asthenia—Lisinopril—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Carteolol—Headache—Mycophenolic acid—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Carteolol—Nausea—Leflunomide—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Carteolol—Vision blurred—Prednisone—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Carteolol—Dizziness—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Carteolol—Nausea—Mycophenolic acid—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Carteolol—Syncope—Prednisone—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Carteolol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Carteolol—Loss of consciousness—Prednisone—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Carteolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Carteolol—Headache—Lisinopril—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Carteolol—Nausea—Lisinopril—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Carteolol—Oedema—Prednisone—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Carteolol—Shock—Prednisone—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Carteolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Carteolol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Carteolol—Insomnia—Prednisone—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Carteolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Carteolol—Hypotension—Methotrexate—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Carteolol—Insomnia—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Carteolol—Dyspnoea—Methotrexate—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Carteolol—Hypersensitivity—Prednisone—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Carteolol—Asthenia—Prednisone—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Carteolol—Dizziness—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Carteolol—Headache—Prednisone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Carteolol—Asthenia—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Carteolol—Nausea—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Carteolol—Dizziness—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Carteolol—Headache—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Carteolol—Nausea—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
